What is the address of fLORIN HENDRIK-JAN, UROLOGIE BV?

The registered office of fLORIN HENDRIK-JAN, UROLOGIE BV is located at Elsstraat-Zuid 28, 9140 Temse.

Is fLORIN HENDRIK-JAN, UROLOGIE BV still active?

Yes. According to the CBE (29 September 2026) fLORIN HENDRIK-JAN, UROLOGIE BV is active, legal situation “Normale toestand”, started on 15 January 2020.

Is fLORIN HENDRIK-JAN, UROLOGIE BV registered on Peppol?

Yes, fLORIN HENDRIK-JAN, UROLOGIE BV is registered on the Peppol network with ID 0208:0741572225.

What is the enterprise number of fLORIN HENDRIK-JAN, UROLOGIE BV?

The enterprise number of fLORIN HENDRIK-JAN, UROLOGIE BV is BE0741572225.

When was fLORIN HENDRIK-JAN, UROLOGIE BV founded?

fLORIN HENDRIK-JAN, UROLOGIE BV was founded on 15 January 2020.

Who are the directors of fLORIN HENDRIK-JAN, UROLOGIE BV?

According to the 2025 annual accounts, the directors of fLORIN HENDRIK-JAN, UROLOGIE BV are: Hendrik-Jan Florin.

Is fLORIN HENDRIK-JAN, UROLOGIE BV a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 15 January 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did fLORIN HENDRIK-JAN, UROLOGIE BV make in 2025?

fLORIN HENDRIK-JAN, UROLOGIE BV posted a profit after taxes of € 159,426 in financial year 2025.

What is the revenue of fLORIN HENDRIK-JAN, UROLOGIE BV?

As a small company, fLORIN HENDRIK-JAN, UROLOGIE BV is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 220,920.

fLORIN HENDRIK-JAN, UROLOGIE BV (Private Limited) - Temse

Dossier fLORIN HENDRIK-JAN, UROLOGIE BV, printed on 29 September 2026 from databakkes.be/en/0741572225/florin-hendrik-jan-urologie-bv. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

fLORIN HENDRIK-JAN, UROLOGIE BV from Temse, company number BE0741572225, closed financial year 2025 with a result of € 159,426 after tax. For that financial year fLORIN HENDRIK-JAN, UROLOGIE BV recorded a gross margin of € 220,920 and equity of € 5,000. Compared with financial year 2024, the result moved from € 164,435 to € 159,426. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 22, 2026.

What it is worth Healthy

€ 5,000

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 159,426

▼ 3% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 88,460

▼ 40% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 159,426 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 6,134

▼ 56% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 6,628

▼ 54% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 1,306

▼ 4% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 3,500

▼ 36% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 183,339 Gross margin 2022: € 183,339 First fiscal year in the series	€ 253,917 Gross margin 2023: € 253,917 ▲ 38% vs 2022 (€ 183,339) Favourable step	€ 224,746 Gross margin 2024: € 224,746 ▼ 11% vs 2023 (€ 253,917) Unfavourable step	€ 220,920 Gross margin 2025: € 220,920 ▼ 2% vs 2024 (€ 224,746) Unfavourable step	▼ 2%
Profit after taxes	€ 134,114 Profit after taxes 2022: € 134,114 First fiscal year in the series	€ 181,165 Profit after taxes 2023: € 181,165 ▲ 35% vs 2022 (€ 134,114) Favourable step	€ 164,435 Profit after taxes 2024: € 164,435 ▼ 9% vs 2023 (€ 181,165) Unfavourable step	€ 159,426 Profit after taxes 2025: € 159,426 ▼ 3% vs 2024 (€ 164,435) Unfavourable step	▼ 3%
Equity	€ 321,453 Equity 2022: € 321,453 First fiscal year in the series	€ 220,279 Equity 2023: € 220,279 ▼ 31% vs 2022 (€ 321,453) Unfavourable step	€ 5,000 Equity 2024: € 5,000 ▼ 98% vs 2023 (€ 220,279) Unfavourable step	€ 5,000 Equity 2025: € 5,000 Unchanged (€ 5,000) Unchanged
Total debts	€ 58,166 Total debts 2022: € 58,166 First fiscal year in the series	€ 53,375 Total debts 2023: € 53,375 ▼ 8% vs 2022 (€ 58,166) Favourable step	€ 185,794 Total debts 2024: € 185,794 ▲ 248% vs 2023 (€ 53,375) Unfavourable step	€ 170,859 Total debts 2025: € 170,859 ▼ 8% vs 2024 (€ 185,794) Favourable step	▼ 8%
Cash	€ 313,986 Cash 2022: € 313,986 First fiscal year in the series	€ 242,271 Cash 2023: € 242,271 ▼ 23% vs 2022 (€ 313,986) Unfavourable step	€ 147,822 Cash 2024: € 147,822 ▼ 39% vs 2023 (€ 242,271) Unfavourable step	€ 88,460 Cash 2025: € 88,460 ▼ 40% vs 2024 (€ 147,822) Unfavourable step	▼ 40%
Retained profit	€ 316,453 Retained profit 2022: € 316,453 First fiscal year in the series	€ 215,279 Retained profit 2023: € 215,279 ▼ 32% vs 2022 (€ 316,453) Unfavourable step	€ 0 Retained profit 2024: € 0 ▼ 100% vs 2023 (€ 215,279) Unfavourable step	€ 0 Retained profit 2025: € 0 Unchanged (€ 0) Unchanged
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 282,339 Dividend 2023: € 282,339 Unchanged (€ 0) Unchanged	€ 379,714 Dividend 2024: € 379,714 ▲ 34% vs 2023 (€ 282,339) Unchanged	€ 159,426 Dividend 2025: € 159,426 ▼ 58% vs 2024 (€ 379,714) Unchanged	▼ 58%
Bank debt	€ 30,058 Bank debt 2022: € 30,058 First fiscal year in the series	€ 22,322 Bank debt 2023: € 22,322 ▼ 26% vs 2022 (€ 30,058) Favourable step	€ 14,512 Bank debt 2024: € 14,512 ▼ 35% vs 2023 (€ 22,322) Favourable step	€ 6,628 Bank debt 2025: € 6,628 ▼ 54% vs 2024 (€ 14,512) Favourable step	▼ 54%
Balance sheet total	€ 379,620 Balance sheet total 2022: € 379,620 First fiscal year in the series	€ 273,653 Balance sheet total 2023: € 273,653 ▼ 28% vs 2022 (€ 379,620) Unchanged	€ 190,794 Balance sheet total 2024: € 190,794 ▼ 30% vs 2023 (€ 273,653) Unchanged	€ 175,859 Balance sheet total 2025: € 175,859 ▼ 8% vs 2024 (€ 190,794) Unchanged	▼ 8%

Key figures of fLORIN HENDRIK-JAN, UROLOGIE BV, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to fLORIN HENDRIK-JAN, UROLOGIE BV?

What happened at fLORIN HENDRIK-JAN, UROLOGIE BV in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 22, 2026 New annual accounts for financial year 2025: profit of € 159,426 (▼ 3% vs 2024). Source: NBB ↗
Jan 15, 2020 New establishment in Temse. KBO
2020 Hendrik-Jan Florin became a director. NBB
Jan 15, 2020 Start of the company according to the CBE. KBO

In short

From € 134,114 profit in 2022 to € 159,426 profit in 2025.

Paid € 203,354 in corporate taxes since 2022.

Best year ever: 2023, with € 181,165 profit.

Paid out € 821,479 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at fLORIN HENDRIK-JAN, UROLOGIE BV? We notify you, reason included.

Follow fLORIN HENDRIK-JAN, UROLOGIE BV

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Hendrik-Jan Florin

fLORIN HENDRIK-JAN, UROLOGIE BV

Behind fLORIN HENDRIK-JAN, UROLOGIE BV is Hendrik-Jan Florin.

See the full network in the app

Directors

According to the 2025 annual accounts

Hendrik-Jan Florin

Director

since 2020

Establishments

Establishment units

Physical locations of this company

Registered office

Elsstraat-Zuid 28

9140 Temse

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

VAN DAMME LIESBETH, PEDIATER BV

€ 103,540 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0741.572.225
VAT number: BE 0741.572.225
Registered office: Elsstraat-Zuid 28, 9140 Temse
Names & denominations: fLORIN HENDRIK-JAN, UROLOGIE BV
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 15 January 2020
Peppol: Active · Active since 19 Jan 2026

View on CBE Public ↗ Annual accounts (NBB) ↗